{"disease":{"id":"breast-cancer-nos-metastatic-recurrent","name":"breast cancer nos metastatic recurrent"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01554371","title":"Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT01703754","title":"Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Alaunos Therapeutics","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}